NLM Digital Collections

Search

Start Over Collections Health Policy and Services Research ✖Remove constraint Collections: Health Policy and Services Research Subjects Government Regulation ✖Remove constraint Subjects: Government Regulation Publication Year 2018 ✖Remove constraint Publication Year: <span class="single" data-blrl-single="2018">2018</span>

1. State regulation of coverage options outside of the Affordable Care Act: limiting the risk to the individual market

Author(s):
Lucia, Kevin, author
Giovannelli, Justin, author
Corlette, Sabrina, author
Volk, JoAnn, author
Palanker, Dania, author
Kona, Maanasa, author
Curran, Emily, author
Publication:
[New York, N.Y.] : Commonwealth Fund, March 2018
Subject(s):
Government Regulation
Insurance Benefits -- economics
Insurance Coverage -- economics
Insurance Selection Bias
Insurance, Health -- economics
Insurance, Health -- legislation & jurisprudence
State Government
Federal Government
Health Care Sector
Health Policy
Humans
United States
United States.

2. Short-term, limited-duration insurance and risks to California's insurance market

Author(s):
Palanker, Dania, author
Lucia, Kevin, author
Volk, JoAnn, author
Schwab, Rachel, author
Publication:
[Oakland, Calif.] : California Health Care Foundation, April 2018
Subject(s):
Health Insurance Exchanges
Insurance, Health
Health Care Sector
Insurance Benefits
Government Regulation
State Government
Humans
California
United States
United States.

3. Ensuring health plan mergers benefit the community: California regulators and infrastructure investment programs

Author(s):
Shore, Karen, author
Publication:
[Oakland, Calif.] : California Health Care Foundation, July 2018
Subject(s):
For-Profit Insurance Plans -- organization & administration
Health Care Coalitions -- organization & administration
Investments
Insurance Benefits
Insurance Carriers -- statistics & numerical data
Insurance, Health
Safety-net Providers
For-Profit Insurance Plans -- economics
Government Regulation
Health Care Coalitions -- economics
Health Care Sector
Organizational Case Studies
State Government
Humans
California
United States

4. Prescription opioids: Medicare should expand oversight efforts to reduce the risk of harm : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, January 17, 2018
Subject(s):
Drug and Narcotic Control
Inappropriate Prescribing -- prevention & control
Medicare Part D -- statistics & numerical data
Opioid-Related Disorders
Prescription Drug Misuse -- statistics & numerical data
Analgesics, Opioid -- adverse effects
Fraud -- prevention & control
Government Regulation
Inappropriate Prescribing -- statistics & numerical data
Medicare Part D -- economics
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

5. California's nurse practitioners: how scope of practice laws impact care

Author(s):
Spetz, Joanne, author
Publication:
[Oakland, Calif.] : California Health Care Foundation, September 2018
Subject(s):
Health Workforce -- statistics & numerical data
Nurse Practitioners -- statistics & numerical data
Nurse's Role
Quality of Health Care
Cost-Benefit Analysis
Government Regulation
Health Services Accessibility
Nurse Practitioners -- education
Primary Health Care
State Government
Humans
California
United States

6. Medicaid long-term services and supports: access and quality problems in managed care demand improved oversight : report to the chairman, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, November 2020
Subject(s):
Government Regulation
Managed Care Programs
Medicaid -- organization & administration
Government Agencies -- standards
United States
Centers for Medicare & Medicaid Services (U.S.)

8. Drug discount program: status of agency efforts to improve 340B program oversight : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate

Publication:
Washington, DC : United States Government Accountability Office, May 15, 2018
Subject(s):
Drug Costs
Economics, Pharmaceutical
Government Regulation
Medicaid -- economics
United States
United States. Health Resources and Services Administration.

9. Drug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, July 11, 2018
Subject(s):
Drug Costs
Economics, Pharmaceutical
Pharmacies -- economics
Contract Services
Government Regulation
United States
United States. Health Resources and Services Administration.